Literature DB >> 18778100

Lessons from nature: biomimetic organocatalytic carbon-carbon bond formations.

Dieter Enders1, Arun A Narine.   

Abstract

Nature utilizes simple C2 and C3 building blocks, such as dihydroxyacetone phosphate (DHAP), phosphoenolpyruvate (PEP), and the "active aldehyde" in various enzyme-catalyzed carbon-carbon bond formations to efficiently build up complex organic molecules. In this Perspective, we describe the transition from using enantiopure chemical synthetic equivalents of these building blocks, employing our SAMP/RAMP hydrazone methodology and metalated chiral alpha-amino nitriles, to the asymmetric organocatalytic versions developed in our laboratory. Following this biomimetic strategy, the DHAP equivalent 2,2-dimethyl-1,3-dioxan-5-one (dioxanone) has been used in the proline-catalyzed synthesis of carbohydrates, aminosugars, carbasugars, polyoxamic acid, and various sphingosines. Proline-catalyzed aldol reactions involving a PEP-like equivalent have also allowed for the asymmetric synthesis of ulosonic acid precursors. By mimicking the "active aldehyde" nucleophilic acylations in Nature catalyzed by the thiamine-dependent enzyme, transketolase, enantioselective N-heterocyclic carbene-catalyzed benzoin and Stetter reactions have been developed. Finally, based on Nature's use of domino reactions to convert simple building blocks into complex and highly functionalized molecules, we report on our development of biomimetic asymmetric multicomponent domino reactions which couple enamine and iminium catalysis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18778100     DOI: 10.1021/jo801374j

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  16 in total

1.  Exploiting Enzymatic Dynamic Reductive Kinetic Resolution (DYRKR) in Stereocontrolled Synthesis.

Authors:  Gregory A Applegate; David B Berkowitz
Journal:  Adv Synth Catal       Date:  2015-05-12       Impact factor: 5.837

2.  Developing novel organocatalyzed aldol reactions for the enantioselective synthesis of biologically active molecules.

Authors:  Mayur Bhanushali; Cong-Gui Zhao
Journal:  Synthesis (Stuttg)       Date:  2011-06       Impact factor: 3.157

3.  Direct asymmetric vinylogous Michael addition of cyclic enones to nitroalkenes via dienamine catalysis.

Authors:  Giorgio Bencivenni; Patrizia Galzerano; Andrea Mazzanti; Giuseppe Bartoli; Paolo Melchiorre
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

4.  Preparation of 1,5-Dioxaspiro[5.5]undecan-3-one.

Authors:  Robert A Craig; Russell C Smith; Beau P Pritchett; Benzi I Estipona; Brian M Stoltz
Journal:  Organic Synth       Date:  2016

5.  Carbenes as catalysts for transformations of organometallic iron complexes.

Authors:  Vincent Lavallo; Robert H Grubbs
Journal:  Science       Date:  2009-10-23       Impact factor: 47.728

Review 6.  A continuum of progress: applications of N-hetereocyclic carbene catalysis in total synthesis.

Authors:  Javier Izquierdo; Gerri E Hutson; Daniel T Cohen; Karl A Scheidt
Journal:  Angew Chem Int Ed Engl       Date:  2012-10-16       Impact factor: 15.336

7.  Novel bifunctional sulfonamides catalyze an enantioselective conjugate addition.

Authors:  Patrick G McGarraugh; Stacey E Brenner
Journal:  Tetrahedron       Date:  2009-01-10       Impact factor: 2.457

8.  Gold(I)-catalyzed formation of bicyclo[4.2.0]oct-1-enes.

Authors:  Ryan J Felix; Osvaldo Gutierrez; Dean J Tantillo; Michel R Gagné
Journal:  J Org Chem       Date:  2013-05-13       Impact factor: 4.354

9.  Stereoselective synthesis of highly functionalized alpha-diazo-beta-ketoalkanoates via catalytic one-pot Mukaiyama-Aldol reactions.

Authors:  Lei Zhou; Michael P Doyle
Journal:  Org Lett       Date:  2010-02-19       Impact factor: 6.005

10.  An Asymmetric Organocatalytic Quadruple Cascade to Tetraaryl-Substituted 2-Azabicyclo[3.3.0]octadienones.

Authors:  Céline Joie; Kristina Deckers; Gerhard Raabe; Dieter Enders
Journal:  Synthesis (Stuttg)       Date:  2014-06-01       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.